NUTRA PHARMA CORP. Retained Earnings
NUTRA PHARMA CORP. (NPHC) had Retained Earnings of -$82.69 million as of 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-19
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$82.69M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$78.74M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$78.28M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$77.79M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-06-30 | -$82.69M 10-Q · filed 2026-08-19 |
| 2026-03-31 | -$78.74M 10-Q · filed 2026-05-29 |
| 2025-12-31 | -$78.28M 10-Q · filed 2026-08-19 |
| 2025-09-30 | -$77.79M 10-Q · filed 2026-04-06 |
| 2025-06-30 | -$77.27M 10-Q · filed 2026-03-25 |
| 2025-03-31 | -$77.64M 10-Q · filed 2026-03-11 |
| 2024-12-31 | -$76.23M 10-K · filed 2026-05-20 |
| 2024-09-30 | -$76.00M 10-Q · filed 2026-01-02 |
| 2024-06-30 | -$75.74M 10-Q · filed 2025-12-23 |
| 2024-03-31 | -$75.37M 10-Q · filed 2025-12-17 |
| 2023-12-31 | -$74.95M 10-K · filed 2026-02-17 |
| 2023-09-30 | -$74.70M 10-Q · filed 2025-10-28 |
| 2023-06-30 | -$74.42M 10-Q · filed 2025-10-23 |
| 2023-03-31 | -$74.14M 10-Q · filed 2025-10-16 |
| 2022-12-31 | -$73.55M 10-K · filed 2025-11-24 |
| 2022-09-30 | -$76.78M 10-Q · filed 2022-11-21 |
| 2022-06-30 | -$77.36M 10-Q · filed 2022-08-22 |
| 2022-03-31 | -$76.72M 10-Q · filed 2022-05-20 |
| 2021-12-31 | -$81.73M 10-K · filed 2025-09-03 |
| 2021-09-30 | -$83.90M 10-Q · filed 2021-11-10 |
| 2021-06-30 | -$99.33M 10-Q · filed 2021-09-24 |
| 2021-03-31 | -$102.65M 10-Q · filed 2021-09-17 |
| 2020-12-31 | -$68.63M 10-K · filed 2022-04-15 |
| 2020-09-30 | -$66.60M 10-Q · filed 2021-08-12 |
| 2020-06-30 | -$67.19M 10-Q · filed 2021-08-05 |
| 2020-03-31 | -$65.68M 10-Q · filed 2021-07-23 |
| 2019-12-31 | -$67.86M 10-K · filed 2021-09-08 |
| 2019-09-30 | -$63.83M 10-Q · filed 2021-05-14 |
| 2019-06-30 | -$63.34M 10-Q · filed 2021-05-07 |
| 2019-03-31 | -$61.67M 10-Q · filed 2021-04-05 |
| 2018-12-31 | -$61.27M 10-K · filed 2021-07-01 |
| 2018-09-30 | -$63.79M 10-Q · filed 2018-11-19 |
| 2018-06-30 | -$62.83M 10-Q · filed 2018-08-17 |
| 2018-03-31 | -$61.48M 10-Q · filed 2018-05-21 |
| 2017-12-31 | -$57.39M 10-K · filed 2021-02-05 |
| 2017-09-30 | -$56.40M 10-Q · filed 2017-11-20 |
| 2017-06-30 | -$55.41M 10-Q · filed 2017-08-14 |
| 2017-03-31 | -$54.30M 10-Q · filed 2017-05-17 |
| 2016-12-31 | -$53.36M 10-K · filed 2018-04-17 |
| 2016-09-30 | -$52.28M 10-Q · filed 2016-11-22 |
| 2016-06-30 | -$51.64M 10-Q · filed 2016-08-22 |
| 2016-03-31 | -$50.99M 10-Q · filed 2016-06-21 |
| 2015-12-31 | -$49.91M 10-K · filed 2017-04-17 |
| 2015-09-30 | -$50.59M 10-Q · filed 2015-11-23 |
| 2015-06-30 | -$46.65M 10-Q · filed 2015-08-18 |
| 2015-03-31 | -$44.88M 10-Q · filed 2015-05-19 |
| 2014-12-31 | -$44.52M 10-K · filed 2016-04-14 |
| 2014-09-30 | -$43.72M 10-Q · filed 2014-11-14 |
| 2014-06-30 | $43.51M 10-Q · filed 2014-08-14 |
| 2014-03-31 | -$42.19M 10-Q · filed 2014-05-20 |
| 2013-12-31 | -$41.99M 10-K · filed 2015-04-13 |
| 2013-09-30 | -$41.37M 10-Q · filed 2013-11-19 |
| 2013-06-30 | -$38.73M 10-Q · filed 2013-08-19 |
| 2013-03-31 | -$38.12M 10-Q · filed 2013-05-20 |
| 2012-12-31 | -$37.64M 10-K · filed 2014-03-31 |
| 2012-09-30 | -$35.46M 10-Q/A · filed 2012-12-12 |
| 2012-06-30 | -$35.15M 10-Q/A · filed 2012-12-07 |
| 2012-03-31 | -$35.12M 10-Q/A · filed 2012-11-28 |
| 2011-12-31 | -$34.03M 10-K · filed 2013-04-16 |
| 2011-09-30 | -$31.53M 10-Q · filed 2011-11-15 |
| 2011-06-30 | -$30.87M 10-Q · filed 2011-08-15 |
| 2010-12-31 | -$29.63M 10-K/A · filed 2012-11-15 |